Single-dose studies demonstrated close to linear pharmacokinetics of vericiguat for AUC and a slight trend in decreasing C max with increasing doses.
← all excerpts
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
1
—
—